Suven Pharma To Acquire Sapala Organic For Rs 230 Crore

Suven Pharmaceuticals, which is backed by PE company Advent International, said that it has reached a definitive agreement to acquire a controlling stake in Hyderabad-based contract research development organization (CDMO) Sapala Organic for...

Cumulus Neuroscience and DiMe Partner on Framework for Digital Endpoints

Cumulus Neuroscience, a worldwide digital health company dedicated to improving data for neuroscience clinical trials and patient care, has announced a collaboration with the Digital Health Measurement Collaborative Community (DATAcc) of the...

NewAmsterdam Pharma Secures US Patent For Obicetrapib

NewAmsterdam Pharma Organization N.V., a clinical biopharmaceutical organization creating oral, non-statin prescriptions for patients at risk of cardiovascular disease (CVD) with raised low-density lipoprotein cholesterol (LDL-C), for whom...

Dr Reddy's and Ingenus Pharma Ink Pact For Cancer Treatment Injection

Dr Reddy's Laboratories Ltd, an India-based multinational pharmaceutical company, has entered into a licensing agreement with US-based Ingenus Pharmaceuticals, LLC to market cyclophosphamide injection, which is used to treat cancer...

US FDA Grants Accelerated Nod for Ipsen's Iqirvo

Ipsen announced that Iqirvo (elafibranor) 80 mg tablets have received accelerated approval from the US Food and Drug Administration (FDA) to treat primary biliary cholangitis (PBC) in adults who do not respond well to ursodeoxycholic acid (UDCA)...

Glenmark Bags US FDA Approval for Esomeprazole Magnesium

Glenmark Specialty SA (Glenmark) has received final approval by the United States Food & Drug Administration (FDA) for esomeprazole magnesium delayed-release capsules USP, 20 mg (OTC), determined by the FDA to be bioequivalent to Nexium 24 HR...

© 2024 India Pharma Outlook. All Rights Reserved.